VERTEX PHARMACEUTICALS INC / MA (VRTX)

Vertex Pharmaceuticals, Inc. is a global biotechnology company, which engages in the business of discovering, developing, manufacturing, and commercializing small molecule drugs for patients with serious diseases. The firm focuses on development and commercializing therapies for the treatment of cystic fibrosis, infectious diseases including viral infections such as influenza and bacterial infections, autoimmune diseases such as rheumatoid arthritis, cancer, inflammatory bowel disease and neurological disorders including pain and multiple sclerosis. The company was founded by Joshua S. Boger in 1989 and is headquartered in Boston, MA.

Address

50 NORTHERN AVENUE

BOSTON, MA 02210

Founded

1989

Number of Employees

5,400

Website

http://www.vrtx.com

Buyback

Buyback Data	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
$ Amount Purchased ($ in 000s)	-	-	-	-	$349,998	$185,998	$539,082	$1,425,270	-	$427,605	$456,211	$564,027
Average Price	-	-	-	-	$162.55	$175.75	$224.16	$196.10	-	$331.71	$425.66	$221.98
# Shares Purchased	-	-	-	-	2,153,152	1,058,319	2,404,859	7,268,144	-	1,289,076	1,071,773	2,540,887

Buyback Performance	2014	2015	2016	2017	2018	2019	2020	2021	2022	2023	2024	Average
Total Return to Date	-	-	-	-	198.4%	176.0%	116.4%	147.3%	-	46.2%	13.9%	118.5%
S&P 500 Return to Date	-	-	-	-	104.9%	93.1%	74.8%	31.7%	-	31.3%	7.4%	57.2%
Excess Total Return	-	-	-	-	93.5%	82.9%	41.5%	115.7%	-	14.9%	6.5%	61.3%
Quartile Rank
Percentile Rank	-	-	-	-	87%	85%	77%	95%	-	81%	69%	87%

Buyback returns calculated using weighted average buyback price over the last 10 years and comparing to current day stock price value. S&P 500 used as benchmark for excess return.

Insider Transactions

Filters

Keyboard Shortcuts: Show (a) | Close (Esc)

People also followed

BOGER JOSHUA S

VERTEX PHARMACEUTICALS INC / MA

INCYTE CORP

BRUM LYNNE H

VERTEX PHARMACEUTICALS INC / MA